« Back to Record
Citation APA

Taieb, J., Tabernero, J., Mini, E., Subtil, F., Folprecht, G., Van Laethem, J.-L., Thaler, J., Bridgewater, J., Petersen, L. N., Blons, H., Collette, L., Van Cutsem, E., Rougier, P., Salazar, R., Bedenne, L., Emile, J.-F., Laurent-Puig, P., Lepage, C., & PETACC-8 Study Investigators, (2014). Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. Lancet oncology, 15(8), 862-873. doi:10.1016/S1470-2045(14)70227-X


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/186439

Taieb, J., Tabernero, J., Mini, E., Subtil, F., Folprecht, G., Van Laethem, J.-L., Thaler, J., Bridgewater, J., Petersen, L. N., Blons, H., Collette, L., Van Cutsem, E., Rougier, P., Salazar, R., Bedenne, L., Emile, J.-F., Laurent-Puig, P., Lepage, C., & PETACC-8 Study Investigators, (2014). Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. Lancet oncology, 15(8), 862-873. doi:10.1016/S1470-2045(14)70227-X